新型头孢菌素的药代动力学特性。药物选择的有效依据？ - Suppr

Suppr

超能文献

Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?

作者信息

Noble J T, Barza M

出版信息

Drugs. 1985 Sep;30(3):175-81. doi: 10.2165/00003495-198530030-00001.

DOI:10.2165/00003495-198530030-00001

PMID:3899596

Abstract

摘要

相似文献

Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?新型头孢菌素的药代动力学特性。药物选择的有效依据？

Drugs. 1985 Sep;30(3):175-81. doi: 10.2165/00003495-198530030-00001.

Diffusibility of the newer cephalosporins into human interstitial fluids.

Am J Med. 1984 Oct 19;77(4C):33-6.

Entry of four cephalosporins into the ovine lung.

J Infect Dis. 1984 Feb;149(2):264-70. doi: 10.1093/infdis/149.2.264.

Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.

J Antimicrob Chemother. 1982 Nov;10 Suppl C:99-104. doi: 10.1093/jac/10.suppl_c.99.

The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.新型β-内酰胺类抗生素的体外活性、人体药理学及临床疗效

Annu Rev Pharmacol Toxicol. 1982;22:599-642. doi: 10.1146/annurev.pa.22.040182.003123.

Pharmacokinetics of the new cephalosporins.新型头孢菌素的药代动力学

Antibiot Chemother (1971). 1982;31:145-210. doi: 10.1159/000400133.

Affinity of cefmenoxime for beta-lactamases: an analysis.头孢甲肟对β-内酰胺酶的亲和力：一项分析

Am J Med. 1984 Dec 21;77(6A):25-7. doi: 10.1016/s0002-9343(84)80070-4.

Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.正常志愿者中拉氧头孢、头孢哌酮和头孢噻肟的比较药代动力学

Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S585-94. doi: 10.1093/clinids/4.supplement_3.s585.

Third-generation cephalosporins: a critical evaluation.第三代头孢菌素：批判性评价

Clin Pharm. 1984 Jul-Aug;3(4):351-73.

Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.头孢曲松：延长第三代头孢菌素的半衰期并增强其活性。

Pediatr Infect Dis. 1985 Mar-Apr;4(2):188-91.

引用本文的文献

Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.第三代头孢菌素的药物利用评价。重点关注头孢曲松、头孢他啶和头孢噻肟。

Drugs. 1995 Sep;50(3):423-39. doi: 10.2165/00003495-199550030-00002.

Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid.

Eur J Drug Metab Pharmacokinet. 1987 Apr-Jun;12(2):91-102. doi: 10.1007/BF03189882.

Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans.广谱胃肠外抗生素对人体肠道微生物群组成的影响。

Antimicrob Agents Chemother. 1987 Feb;31(2):202-6. doi: 10.1128/AAC.31.2.202.

Dosage adjustment for ceftazidime in patients with impaired renal function.

Eur J Clin Pharmacol. 1986;30(5):597-605. doi: 10.1007/BF00542421.

Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum.将替莫西林注入兔血浆以模拟人血清中的抗生素浓度后，其在实验性肺炎克雷伯菌脑膜炎中的疗效。

Antimicrob Agents Chemother. 1988 Nov;32(11):1705-9. doi: 10.1128/AAC.32.11.1705.

Current concepts in the treatment of genitourinary tract disorders in the older individual.老年个体泌尿生殖道疾病治疗的当前概念。

Drugs Aging. 1991 May;1(3):176-93. doi: 10.2165/00002512-199101030-00003.

本文引用的文献

The new beta-lactamase-stable cephalosporins.新型β-内酰胺酶稳定的头孢菌素。

Ann Intern Med. 1982 Sep;97(3):408-19. doi: 10.7326/0003-4819-97-3-408.

Effect of cefoperazone on faecal flora.

J Antimicrob Chemother. 1983 Aug;12(2):163-7. doi: 10.1093/jac/12.2.163.

Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics.含N-甲基硫代四氮唑抗生素抑制谷氨酸γ-羧化作用的机制。

Proc Natl Acad Sci U S A. 1984 May;81(9):2893-7. doi: 10.1073/pnas.81.9.2893.

Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.头孢哌酮：对其体外抗菌活性、药理特性及治疗效果的综述。

Drugs. 1981 Dec;22(6):423-60. doi: 10.2165/00003495-198122060-00002.

Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.正常肾功能和肾功能受损受试者中莫拉卡坦的药代动力学。

Antimicrob Agents Chemother. 1981 Jun;19(6):965-71. doi: 10.1128/AAC.19.6.965.

Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora.发热性中性粒细胞减少症癌症患者的低凝血酶原血症：与肠道微生物群的抗菌抑制作用相关

J Infect Dis. 1984 Aug;150(2):202-12. doi: 10.1093/infdis/150.2.202.

Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.头孢他啶的多剂量药代动力学及其对粪便菌群的影响。

Antimicrob Agents Chemother. 1983 Sep;24(3):333-8. doi: 10.1128/AAC.24.3.333.

Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。

Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.

Studies on absorption, distribution, metabolism and excretion of ceftazidime in Japan.

J Antimicrob Chemother. 1983 Jul;12 Suppl A:255-62. doi: 10.1093/jac/12.suppl_a.255.

Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢曲松。对其抗菌活性、药理特性及治疗用途的综述。

Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验